Effect of Different Treating Principles and Formulas on Expression of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand mRNA in Steroid-induced Osteonecrosis of Femoral Head in Chichen
|更新时间:2024-01-04
|
Effect of Different Treating Principles and Formulas on Expression of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand mRNA in Steroid-induced Osteonecrosis of Femoral Head in Chichen
Chinese Journal of Experimental Traditional Medical FormulaeVol. 17, Issue 8, Pages: 149-153(2011)
WAN Rong, LI Li, KONG Xiang-ying, et al. Effect of Different Treating Principles and Formulas on Expression of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand mRNA in Steroid-induced Osteonecrosis of Femoral Head in Chichen[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(8): 149-153.
DOI:
WAN Rong, LI Li, KONG Xiang-ying, et al. Effect of Different Treating Principles and Formulas on Expression of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand mRNA in Steroid-induced Osteonecrosis of Femoral Head in Chichen[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(8): 149-153. DOI: CNKI:11-3495/R.20110303.1347.004.
Effect of Different Treating Principles and Formulas on Expression of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand mRNA in Steroid-induced Osteonecrosis of Femoral Head in Chichen
Objective: To investigate the effect of two treating principles and formulas
named 'invigorating spleen to remove phlem and promoting blood circulation to remove meridian obstruction’(Jianpi) and 'invigorate the kidney and promoting blood circulation to remove meridian obstruction’(Bushen)
on the expression of osteoprotegerin(OPG) and receptor activator of nuclear factor-κB ligand(RANKL) mRNA in steroid-induced osteonecrosis of the femoral head(SONFH)
as well as to explore and compare their mechanism of prevention and treatment for SONFH. Method: Sixty-four chickens were randomly divided into control group
model group
Jianpi group and Bushen group. Except the control group
the animal model of SONFH was established with injection of methylprednisolone in chest muscle of chickens. At 8th and 16th weeks
both sides of femoral heads were taken off to observe the expression of OPG and RANKL mRNA with in situ hybridization staining. Result: Compared with the control group
the expression of OPG mRNA was decreased and RANKL mRNA increased significantly in model group(P<0.01). Compared with model group
both in Jianpi and Bushen group
the expression of OPG mRNA was increased and RANKL mRNA decreased significantly
meanwhile the ratio of OPG to RANKL was increased(P<0.01 or P<0.001). In Bushen group
the change did not obvious at the 8th weeks
however
the changes were significant compared with that in Jianpi group at the 16th weeks. Conclusion: Both Jianpi and Bushen formula can regulate the expression of OPG and RANKL mRNA to inhibit bone destruction
thereby exert preventive and therapeutic effect for SONFH. Jianpi take action earlier than Bushen formula.